Neuronet aims to help scientists to identify gaps in research, to make findings more visible for society as a whole and create links between Innovative Medicines Initiative projects and other international research initiatives.

Visit Neuronet to learn about the various research projects launched by the Innovative Medicines Initiative (IMI), Europe’s biggest public and private collaboration in life sciences, aiming to better understand and develop treatments for neurological conditions, including Parkinson’s.

PD-MitoQUANT researchers have participated in Neuronet conference sessions and engaged with the Neuronet consortium through their popular social media campaigns. Here are a few examples of our Neuronet engagement activities.

Jochen Prehn RCSI

PD-MitoQUANT Coordinator Prof Jochen Prehn, of the RCSI, participated in a Neuronet roundtable session titled: “Public-private partnerships in the post-COVID era” at the Alzheimer Europe Conference 2020 on October 22, 2020. Read the full story.

On September 24, 2020, Dr Shruti Desai, a postdoc at Radboud University Nijmegen Medical Center within the Radboud Center for Mitochondrial Medicine (RCMM) responded to questions about her work as part of Neuronet’s series of interviews where they highlighted early-career investigators. Find the engaging interview here.

As part of Neuronet’s #WeAreNeuronet campaign to celebrate the great people behind the projects, Dr Orla Watters, a member of the PD-MitoQUANT research team at the RCSI (Royal College of Surgeons Ireland) featured on August 25, 2020.

Continuing the #WeAreNeuronet campaign to celebrate IMI projects and the great people behind them, Dana Bar-On, PD-MitoQUANT EFPIA Project Leader and Director of Teva Pharmaceutical Industries Ltd‘s Global R & D Academic Affairs featured.